Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 03, 2021

SELL
$130.46 - $172.63 $847,990 - $1.12 Million
-6,500 Closed
0 $0
Q3 2020

Nov 10, 2020

BUY
$146.22 - $169.13 $950,430 - $1.1 Million
6,500 New
6,500 $962,000
Q1 2019

Jun 14, 2019

SELL
$111.31 - $131.02 $968,397 - $1.14 Million
-8,700 Closed
0 $0
Q4 2018

Jun 20, 2019

BUY
$105.9 - $118.64 $921,330 - $1.03 Million
8,700 New
8,700 $1.01 Million
Q3 2018

Jun 20, 2019

SELL
$85.86 - $107.31 $343,440 - $429,240
-4,000 Closed
0 $0
Q2 2018

Jun 20, 2019

BUY
$75.7 - $86.88 $302,800 - $347,520
4,000 New
4,000 $341,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $743B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Toews Corp Portfolio

Follow Toews Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toews Corp , based on Form 13F filings with the SEC.

News

Stay updated on Toews Corp with notifications on news.